Lactobacillus crispatus 7-4 Mitigates Salmonella typhimurium-Induced Enteritis via the γ‑Glutamylcysteine-Mediated Nrf2 Pathway
Probiotics and Antimicrobial Proteins · 2025
DOI: 10.1007/s12602-024-10294-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Probiotics and Antimicrobial Proteins, 2025. Verfasst von Huixian Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjin…. Hauptthemen laut MEDLINE: Salmonella typhimurium, NF-E2-Related Factor 2, Enteritis, Probiotics. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Key R&D Program, he Forestry Science and Technology Innovation and Promotion Project of Jiangsu Province, the Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Salmonella typhimurium (S. typhimurium) constitutes a major public health concern. We have previously proven that Lactobacillus crispatus 7-4 (L. crispatus 7-4) can inhibit the growth of S. typhimurium and thus can be used as a biocontrol strategy to suppress foodborne S. typhimurium infections. However, the inhibitory effect and in-depth mechanism of L. crispatus 7-4 remain to be elucidated. In this study, we found that L. crispatus 7-4 can protect against S. typhimurium-induced ileum injury by promoting intestinal barrier integrity, maintaining intestinal mucosal barrier homeostasis, and reducing intestinal inflammatory response. Furthermore, we demonstrated that this probiotic strain can increase the abundance of Lactobacillus spp. to maintain microbial homeostasis and simultaneously increase the amount of γ‑glutamylcysteine (γ-GC) by activating the glutathione metabolic pathway. The increased γ-GC promoted the transcription of Nrf2 target genes, thereby improving the host antioxidant level, reducing reactive oxygen species (ROS) accumulation, and removing pro-inflammatory cytokines. In other words, L. crispatus 7-4 could activate the enterocyte Nrf2 pathway by improving γ-GC to protect against S. typhimurium-induced intestinal inflammation and oxidative damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China.
- Pure&Natural (Shanghai) Biotechnology Co., Ltd., Shanghai, 201112, China.
- MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China. suquan.song@njau.edu.cn.
Förderung
- National Key R&D Program
- he Forestry Science and Technology Innovation and Promotion Project of Jiangsu Province
- the Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Wu, H., Ding, C., Chi, C., Liu, S., Gao, Z., Sun, W., Zhao, H., & Song, S. (2025). Lactobacillus crispatus 7-4 Mitigates Salmonella typhimurium-Induced Enteritis via the γ‑Glutamylcysteine-Mediated Nrf2 Pathway. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-024-10294-4
Vancouver
Wu H, Ding C, Chi C, Liu S, Gao Z, Sun W, et al. Lactobacillus crispatus 7-4 Mitigates Salmonella typhimurium-Induced Enteritis via the γ‑Glutamylcysteine-Mediated Nrf2 Pathway. Probiotics and Antimicrobial Proteins. 2025. doi:10.1007/s12602-024-10294-4
BibTeX
@article{Wu2025,
author = {Wu, Huixian and Ding, Chenchen and Chi, Chunyan and Liu, Shuhui and Gao, Zhangshan and Sun, Weidong and Zhao, Haiming and Song, Suquan},
title = {Lactobacillus crispatus 7-4 Mitigates Salmonella typhimurium-Induced Enteritis via the γ‑Glutamylcysteine-Mediated Nrf2 Pathway},
journal = {Probiotics and Antimicrobial Proteins},
year = {2025},
doi = {10.1007/s12602-024-10294-4}
}
EUVIMED